J. Teagarden, DMH, MA

Represented: Patients, Caregivers, and Patient Advocates

Conflicts of Interest:

As of December 17, 2014:

• California Health Benefits Review Program National Advisory Council, Member
• Deans Advisory Council, University of Illinois College of Pharmacy, Member
• Keck Graduate Institute Advisory Council, Member
• Keck Graduate Institute School of Pharmacy Advisory Board, Member
• Medicare Evidence Development & Coverage Advisory Committee, Member
• National Organization for Rare Disorders, Former Employee
• Rare Disease Report, Contributing Writer
• United States Pharmacopeial Convention Therapeutic Information and Formulary Support Expert Committee, Member
• Affiliated with Epstein Health, LLC for funded research programs
• Affiliated with Avalere Health, LLC as senior advisor
• Affiliated with Banner Life Sciences as advisor
• Participated in research on formulary coverage of orphan drugs that involved NORD receiving restricted funding from Novartis and CSL Behring for separate studies
• Participated on technical expert panel for AHRQ-funded special issue of the Journal of General Internal Medicine; NORD received funding
• Received funding from National Pharmaceutical Council for participating in ethics research involving formulary tiering processes

Teagarden served as a member of the Advisory Panel on Rare Disease from April 2013 - September 2015.